跳至主要内容
临床试验/IRCT201306015605N1
IRCT201306015605N1已完成2 期

The efficacy of complementory use of memantine in treatment of schizophrenia with chronic course

Clinical psychiatry research center, Tabriz university of medical sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Exclusion criteria:
  • Substance abuse; IQ of less than 70; Medical history of other mental disorder; Other clinical and neurological disorders; Taking antipsychotic medications during last week or long acting antipsychotic medications during past month; Receiving ECT in the past two weeks; Sensitivity to Memantine

排除标准

  • 未提供

研究者

发起方
Clinical psychiatry research center, Tabriz university of medical sciences

相似试验